Reletter
Artwork for Day 8

Day 8

Mary Talley Bowden MD

Fighting for Physician and Patient Autonomy

Platform
Substack
PricingOnly free issuesPublishesWeekly
Issues39SubscribersRead drbowden.substack.com

Curious about how many subscribers Day 8 has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.

Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.

Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.

Contact Information
How Many Subscribers?
Reletter gives you subscriber numbers, contacts, chart rankings, traffic estimates and more across 1.6m+ newsletters.

Chart Rankings

How this newsletter ranks in the official Substack charts.

Latest Issues

Recent posts by this newsletter. Browse the email archive.

What would Hippocrates have done?

I was honored to be the keynote speaker at Citizens’ Council for Health Freedom’s annual fundraiser in Minneapolis. CCHF, led by RN Twila Brase, has been fighting for medical freedom for twenty-seven years.

a month ago
77
18

Texas Medical Mafia: Part 2

When I finished residency in 2003 and moved to Texas, TMLT (Texas Medical Liability Trust) was essentially the only malpractice carrier available. Coverage required paying dues to the TMA (Texas Medical Association) which at the time did no...

3 months ago
44
1

The Texas Medical Mafia: Part 1

Heads are spinning in Texas following the indictment of general surgeon Dr. Eithan Haim, a recent graduate of Baylor College of Medicine who - with astounding bravery - exposed Texas Children’s Hospital for continuing to perform gender reas...

5 months ago
81
15

Pierre Kory's Expert Witness Testimony to the Texas Medical Board

My fight with the Texas Medical Board started on December 22, 2021, the same day Simone Gold received a letter from California Medical Board and during a time when medical boards across the country were going on offense against ‘misinformat...

5 months ago
50
10

Authors

The writers behind this newsletter.

  • Mary Talley Bowden MD

    ENT in Houston TX fighting for patient autonomy.

  • Frequently Asked Questions

    How can I access the email archive for Day 8?

    You can find recent issues that have been published by Day 8 on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does Day 8 have?

    To see how many people subscribe to Day 8, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in Day 8?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch Day 8 as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like Day 8?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact Day 8 using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters similar to Day 8?

    Scroll up to where it says Similar Newsletters to see other publications like Day 8. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact Day 8?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.